| Literature DB >> 29079680 |
Hao Song1,2,3, Lu Qi4, Tao Zhang5,2, Hai-Yan Wang5,2.
Abstract
The veined rapa whelk (Rapana venosa) is widely consumed in China. Nevertheless, it preys on oceanic bivalves, thereby reducing this resource worldwide. Its larval metamorphosis comprises a transition from pelagic to benthic form, which involves considerable physiological and structural changes and has vital roles in its natural populations and commercial breeding. Thus, understanding the endogenous microRNAs (miRNAs) that drive metamorphosis is of great interest. This is the first study to use high-throughput sequencing to examine the alterations in miRNA expression that occur during metamorphosis in a marine gastropod. A total of 195 differentially expressed miRNAs were obtained. Sixty-five of these were expressed during the transition from precompetent to competent larvae. Thirty-three of these were upregulated and the others were downregulated. Another 123 miRNAs were expressed during the transition from competent to postlarvae. Ninety-six of these were upregulated and the remaining 27 were downregulated. The expression of miR-276-y, miR-100-x, miR-183-x, and miR-263-x showed a >100-fold change during development, while the miR-242-x and novel-m0052-3p expression levels changed over 3000-fold. Putative target gene coexpression, gene ontology, and pathway analyses suggest that these miRNAs play important parts in cell proliferation, migration, apoptosis, metabolic regulation, and energy absorption. Twenty miRNAs and their target genes involved in ingestion, digestion, cytoskeleton, cell adhesion, and apoptosis were identified. Nine of them were analyzed with real-time polymerase chain reaction (PCR), which showed an inverse correlation between the miRNAs and their relative expression levels. Our data elucidate the role of miRNAs in R. venosa metamorphic transition and serve as a solid basis for further investigations into regulatory mechanisms of gastropod metamorphosis.Entities:
Keywords: gastropod; larval; metamorphic transition; miRNA
Mesh:
Substances:
Year: 2017 PMID: 29079680 PMCID: PMC5714496 DOI: 10.1534/g3.117.300210
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Mapping statistics of the sequencing data
| Sample | Total | rRNA | snRNA | snoRNA | tRNA | known_mirna | novel_mirna | transcriptome | unann | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total sRNAs | ||||||||||
| Pre-CL 1 | 8871613 (100.00%) | 446583 (5.03%) | 3962 (0.04%) | 103 (0.00%) | 15565 (0.18%) | 5976796 (67.37%) | 6857 (0.08%) | 489213 (5.51%) | 1932534 (21.78%) | |
| Pre-CL 2 | 9550589 (100.00%) | 517504 (5.42%) | 3535 (0.04%) | 91 (0.00%) | 16463 (0.17%) | 6050397 (63.35%) | 8005 (0.08%) | 529334 (5.54%) | 2425260 (25.39%) | |
| Pre-CL 3 | 8828363 (100.00%) | 430096 (4.87%) | 3832 (0.04%) | 179 (0.00%) | 13317 (0.15%) | 5790774 (65.59%) | 5642 (0.06%) | 548611 (6.21%) | 2035912 (23.06%) | |
| CL 1 | 10694742 (100.00%) | 381354 (3.57%) | 2904 (0.03%) | 293 (0.00%) | 9822 (0.09%) | 6671240 (62.38%) | 5372 (0.05%) | 531073 (4.97%) | 3092684 (28.92%) | |
| CL 2 | 10099364 (100.00%) | 323604 (3.20%) | 3067 (0.03%) | 265 (0.00%) | 10247 (0.10%) | 6615421 (65.50%) | 5537 (0.05%) | 459241 (4.55%) | 2681982 (26.56%) | |
| CL 3 | 8705674 (100.00%) | 336962 (3.87%) | 2911 (0.03%) | 124 (0.00%) | 8560 (0.10%) | 5055094 (58.07%) | 4126 (0.05%) | 515795 (5.92%) | 2782102 (31.96%) | |
| PL 1 | 8235539 (100.00%) | 762545 (9.26%) | 11571 (0.14%) | 394 (0.00%) | 79344 (0.96%) | 3788195 (46.00%) | 3570 (0.04%) | 545512 (6.62%) | 3044408 (36.97%) | |
| PL 2 | 9457937 (100.00%) | 659629 (6.97%) | 13152 (0.14%) | 397 (0.00%) | 84076 (0.89%) | 5051974 (53.42%) | 3917 (0.04%) | 502551 (5.31%) | 3142241 (33.22%) | |
| PL 3 | 10159366 (100.00%) | 683232 (6.73%) | 15748 (0.16%) | 365 (0.00%) | 78210 (0.77%) | 5532014 (54.45%) | 4606 (0.05%) | 541416 (5.33%) | 3303775 (32.52%) | |
| Unique sRNAs | ||||||||||
| Pre-CL 1 | 161280 (100.00%) | 18982 (11.77%) | 260 (0.16%) | 30 (0.02%) | 1306 (0.81%) | 19878 (12.33%) | 212 (0.13%) | 22477 (13.94%) | 98135 (60.85%) | |
| Pre-CL 2 | 185539 (100.00%) | 20339 (10.96%) | 269 (0.14%) | 31 (0.02%) | 1313 (0.71%) | 20976 (11.31%) | 211 (0.11%) | 25368 (13.67%) | 117032 (63.08%) | |
| Pre-CL 3 | 188569 (100.00%) | 18343 (9.73%) | 249 (0.13%) | 50 (0.03%) | 1389 (0.74%) | 18263 (9.69%) | 209 (0.11%) | 30383 (16.11%) | 119683 (63.47%) | |
| CL 1 | 222691 (100.00%) | 19494 (8.75%) | 269 (0.12%) | 68 (0.03%) | 1497 (0.67%) | 21033 (9.44%) | 192 0.09%) | 21663 (9.73%) | 158475 (71.16%) | |
| CL 2 | 188340 (100.00%) | 16852 (8.95%) | 220 (0.12%) | 59 (0.03%) | 1362 (0.72%) | 17913 (9.51%) | 191 (0.10%) | 17988 (9.55%) | 133755 (71.02%) | |
| CL 3 | 206425 (100.00%) | 19762 (9.57%) | 229 (0.11%) | 28 (0.01%) | 1284 (0.62%) | 16210 (7.85%) | 181 (0.09%) | 21359 (10.35%) | 147372 (71.39%) | |
| PL 1 | 323650 (100.00%) | 32127 (9.93%) | 580 (0.18%) | 76 (0.02%) | 3619 (1.12%) | 20573 (6.36%) | 173 (0.05%) | 27505 (8.50%) | 238997 (73.84%) | |
| PL 2 | 330025 (100.00%) | 31100 (9.42%) | 635 (0.19%) | 62 (0.02%) | 3432 (1.04%) | 24996 (7.57%) | 205 (0.06%) | 26410 (8.00%) | 243185 (73.69%) | |
| PL 3 | 340097 (100.00%) | 31250 (9.19%) | 630 (0.19%) | 67 (0.02%) | 3424 (1.01%) | 22325 (6.56%) | 207 (0.06%) | 28421 (8.36%) | 253773 (74.62%) | |
Figure 1Differentially expressed miRNAs between groups.
Thirty-nine differentially expressed miRNAs with the following criteria: average TPM >10 (in nine samples), log2Ratio >2 or <-2 and P < 0.01 for ≥1 comparison among groups
| miRNA ID | Average TPM | log2_FC (CL/Pre_CL) | log2_FC (PL/CL) | log2_FC (PL/Pre_CL) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-CL | CL | PL | |||||||
| miR-242-x | 119470.55 | 63690.16 | 30.01 | −0.91 | 0.0051 | −11.05 | 0.0001 | −11.96 | 0.0001 |
| novel-m0052-3p | 8.17 | 0.01 | 36.61 | −9.67 | 0.0001 | 11.84 | 0 | 2.16 | 0.0222 |
| miR-276-y | 44.03 | 0.16 | 36.21 | −8.14 | 0.0078 | 7.85 | 0.006 | −0.28 | 0.9293 |
| miR-100-x | 59.29 | 23.12 | 3972.4 | −1.36 | 0.0538 | 7.42 | 0.0002 | 6.07 | 0 |
| miR-183-x | 51432.32 | 40226.25 | 406.83 | −0.35 | 0.0222 | −6.63 | 0 | −6.98 | 0 |
| miR-263-x | 57623.55 | 41416.09 | 513.61 | −0.48 | 0.0218 | −6.33 | 0 | −6.81 | 0 |
| miR-99-x | 31.73 | 9.45 | 634.7 | −1.75 | 0.0785 | 6.07 | 0 | 4.32 | 0.0015 |
| miR-37-y | 409.54 | 933.54 | 23.69 | 1.19 | 0.0589 | −5.3 | 0 | −4.11 | 0.0019 |
| miR-36-y | 413.61 | 935.84 | 24.25 | 1.18 | 0.0588 | −5.27 | 0 | −4.09 | 0.0018 |
| miR-1175-y | 460.92 | 435.07 | 11573.59 | −0.08 | 0.8908 | 4.73 | 0.0001 | 4.65 | 0.0013 |
| miR-125-x | 13.51 | 5.46 | 132.68 | −1.31 | 0.5297 | 4.6 | 0.0023 | 3.3 | 0.0221 |
| miR-92-x | 67.63 | 54.31 | 3.39 | −0.32 | 0.3449 | −4 | 0 | −4.32 | 0.0001 |
| miR-133-y | 52.35 | 91.6 | 815.97 | 0.81 | 0.1242 | 3.16 | 0.0007 | 3.96 | 0.0007 |
| novel-m0073-3p | 31.68 | 9.14 | 2.31 | −1.79 | 0.0016 | −1.98 | 0.0067 | −3.77 | 0.0009 |
| miR-133-z | 372.85 | 582.47 | 4506.23 | 0.64 | 0.2365 | 2.95 | 0.0013 | 3.6 | 0.0023 |
| miR-278-y | 1107.12 | 2621.61 | 13402.72 | 1.24 | 0.0105 | 2.35 | 0.0001 | 3.6 | 0.0002 |
| miR-3968-y | 35.22 | 10.92 | 3.16 | −1.69 | 0.2069 | −1.79 | 0.0032 | −3.48 | 0.023 |
| miR-283-x | 489.56 | 141.62 | 45.95 | −1.79 | 0.0283 | −1.62 | 0.0004 | −3.41 | 0.0025 |
| miR-1175-x | 76.6 | 45.92 | 455.17 | −0.74 | 0.3242 | 3.31 | 0 | 2.57 | 0.0062 |
| miR-124-y | 40.89 | 171.68 | 388.62 | 2.07 | 0.0004 | 1.18 | 0.002 | 3.25 | 0 |
| miR-1992-y | 75.28 | 45.45 | 429.55 | −0.73 | 0.6242 | 3.24 | 0.0001 | 2.51 | 0.0203 |
| miR-9-y | 20.04 | 15.01 | 132.39 | −0.42 | 0.8649 | 3.14 | 0.0003 | 2.72 | 0.0162 |
| miR-1986-y | 8.86 | 3.05 | 25.27 | −1.54 | 0.0618 | 3.05 | 0.0004 | 1.51 | 0.027 |
| miR-182-x | 46.86 | 21.07 | 156.48 | −1.15 | 0.3974 | 2.89 | 0.0098 | 1.74 | 0.0782 |
| novel-m0121-3p | 10.19 | 9.77 | 68.41 | −0.06 | 0.9767 | 2.81 | 0.0007 | 2.75 | 0.0036 |
| miR-317-y | 115.92 | 104.18 | 731.78 | −0.15 | 0.8325 | 2.81 | 0.0001 | 2.66 | 0.0179 |
| miR-2478-y | 1619.2 | 542.04 | 262.74 | −1.58 | 0.3887 | −1.04 | 0.0096 | −2.62 | 0.1104 |
| let-7-y | 8.32 | 20.49 | 46.93 | 1.3 | 0.0053 | 1.2 | 0.0009 | 2.5 | 0.0004 |
| miR-190-x | 167.59 | 226.25 | 936.13 | 0.43 | 0.2449 | 2.05 | 0 | 2.48 | 0.0032 |
| miR-206-y | 57.9 | 142.27 | 300.9 | 1.3 | 0.0052 | 1.08 | 0.0038 | 2.38 | 0.0001 |
| miR-216-x | 43564.02 | 25139.85 | 9272.06 | −0.79 | 0.0012 | −1.44 | 0.0001 | −2.23 | 0.0001 |
| miR-745-y | 909.71 | 285.74 | 1339.7 | −1.67 | 0.0449 | 2.23 | 0.0001 | 0.56 | 0.253 |
| miR-281-x | 337.71 | 258.01 | 1190.95 | −0.39 | 0.0169 | 2.21 | 0.0001 | 1.82 | 0.0004 |
| miR-278-z | 31.68 | 86.43 | 141.08 | 1.45 | 0.0042 | 0.71 | 0.0009 | 2.15 | 0.0008 |
| miR-219-x | 17.75 | 7.81 | 34.07 | −1.18 | 0.4123 | 2.13 | 0.0002 | 0.94 | 0.1942 |
| miR-277-y | 4.52 | 6.77 | 19.63 | 0.58 | 0.1424 | 1.54 | 0.0046 | 2.12 | 0.0082 |
| miR-1-z | 13128.8 | 27828.43 | 54391.53 | 1.08 | 0.0017 | 0.97 | 0.0016 | 2.05 | 0 |
| miR-981-y | 3915.01 | 7628.17 | 15993.92 | 0.96 | 0.0032 | 1.07 | 0.0026 | 2.03 | 0.0003 |
| miR-278-x | 7.45 | 17.63 | 30.16 | 1.24 | 0.0021 | 0.77 | 0.0083 | 2.02 | 0.0001 |
Figure 2GO terms enrichment of the predicted target genes of differentially expressed miRNAs (P < 0.05).
Figure 3Top 20 pathway enrichment of the predicted target genes of differentially expressed miRNAs. The enrichment factor is the ratio of the number of target genes of differentially expressed miRNAs annotated in this term to the number of all genes annotated in the same term.
Coexpression of 20 key miRNA-targets
| No. | miRNA ID | Average miRNA TPM | Target Gene ID | Average mRNA FPKM | Description | ||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-CL | CL | PL | Pre-CL | CL | PL | ||||
| Ingestion and Digestion | |||||||||
| 1 * | let-7-y | 8.32 | 20.49 | 46.93 | c112229_g1 | 252.36 | 53.19 | 5.87 | SARP-19 precursor |
| 2 * | let-7-y | 8.32 | 20.49 | 46.93 | c124801_g1 | 9144.35 | 2226.16 | 0.13 | Conotoxin Cl14.12 |
| 3 * | let-7-y | 8.32 | 20.49 | 46.93 | c150903_g1 | 69.11 | 2.64 | 1.59 | Exoglucanase XynX |
| 4 * | miR-1175-x | 76.60 | 45.92 | 455.17 | c119967_g1 | 19.39 | 22.63 | 1.05 | Cysteine-rich secretory protein |
| 5 * | miR-2001-x | 87.40 | 171.07 | 278.07 | c154241_g2 | 10.27 | 1.79 | 0.02 | Endo-1,4-β-xylanase A |
| 6 | miR-87-y | 1480.69 | 1819.61 | 4982.30 | c124801_g1 | 9144.35 | 2226.16 | 0.13 | Conotoxin Cl14.12 |
| 7 * | miR-981-y | 3915.01 | 7628.17 | 15993.92 | c137870_g1 | 1261.55 | 85.35 | 0.10 | Endoglucanase E-4 |
| 8 | miR-71-x | 121833.40 | 97302.93 | 49293.23 | c156029_g2 | 1.99 | 4.45 | 63.30 | β-1,4-xylanase |
| 9 | miR-67-y | 12508.03 | 20376.51 | 41820.76 | c156902_g1 | 29.13 | 6.93 | 1.45 | α-amylase 1 |
| 10 | miR-71-x | 121833.40 | 97302.93 | 49293.23 | c152193_g1 | 0.28 | 15.99 | 554.55 | Membrane metallo-endopeptidase-like 1 |
| Cytoskeleton and Cell Adhesion | |||||||||
| 11 | miR-5106-y | 0.68 | 0.99 | 15.98 | c155866_g1 | 833.87 | 122.39 | 14.16 | Tektin-3 |
| 12 | miR-87-y | 1480.69 | 1819.61 | 4982.30 | c157287_g2 | 69.54 | 17.99 | 5.11 | Dynein heavy chain 8, axonemal |
| 13 | miR-315-x | 25652.61 | 30702.55 | 93369.63 | c154991_g1 | 87.45 | 11.55 | 3.14 | Dynein intermediate chain 2, ciliary |
| 14 | miR-283-x | 489.56 | 141.62 | 45.95 | c137644_g1 | 1.61 | 13.81 | 28.09 | Collagen α-5(VI) chain |
| 15 * | miR-263-x | 57623.55 | 41416.09 | 513.61 | c146951_g1 | 46.76 | 47.94 | 82.48 | Src substrate cortactin |
| Apoptosis | |||||||||
| 16 | novel-m0020-5p | 33.74 | 15.18 | 10.35 | c151900_g1 | 4.23 | 4.61 | 10.52 | Apoptosis 2 inhibitor |
| 17 * | miR-276-y | 44.03 | 0.16 | 36.21 | c135194_g1 | 0.78 | 2.54 | 1.25 | Caspase-3 |
| Others | |||||||||
| 18 * | miR-92-x | 67.63 | 54.31 | 3.39 | c140109_g1 | 0.00 | 31.07 | 50.53 | Ependymin |
| 19 | miR-183-x | 51432.32 | 40226.25 | 406.83 | c66957_g1 | 9.40 | 416.76 | 1585.15 | m7GpppN-mRNA hydrolase |
| 20 | miR-216-x | 43564.02 | 25139.85 | 9272.06 | c105989_g1 | 76.77 | 128.87 | 237.52 | Cyclin-I |
Pairs with asterisks were further analyzed by real-time PCR.
Figure 4Real-time PCR analysis for nine target miRNA-mRNA pairs. The appearance of the same letter over matching bars means that there is no significant difference between the stages (P > 0.05). Different letters over matching bars mean significant differences (P < 0.05). Values indicated are means ± SE (N = 5).